COEPTIS THERAPEUTICS HOLDING (COEP) Stock Analyst Ratings
USA - NASDAQ:COEP - US19207A2078 - Common Stock
14.555 USD
+0.4 (+2.86%)
ChartMill assigns a Buy % Consensus number of 43% to COEP. The Buy consensus is the weighted average rating of the current analysts ratings.
COEP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about COEP.
In the previous month the buy percentage consensus was at a similar level.
COEP was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-22 | Ladenburg Thalmann | Initiate | Buy |
| 2023-05-18 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-10 | EF Hutton | Reiterate | Buy |
| 2023-04-19 | JonesTrading | Initiate | Buy |
| 2023-04-05 | EF Hutton | Reiterate | Buy |
| 2023-03-29 | EF Hutton | Reiterate | Buy |
| 2022-12-13 | EF Hutton | Initiate | Buy |
COEPTIS THERAPEUTICS HOLDING / COEP FAQ
What is the consensus rating for COEPTIS THERAPEUTICS HOLDING (COEP) stock?
The consensus rating for COEPTIS THERAPEUTICS HOLDING (COEP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for COEPTIS THERAPEUTICS HOLDING stock?
The number of analysts covering COEPTIS THERAPEUTICS HOLDING (COEP) is 6.